CIK 0001001316
- Large accelerated filer
TG THERAPEUTICS, INC.
Sign in to watch- Ticker
- TGTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363898269
- Phone
- +1 212-554-4484
- Business address
- 2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
- Former names
- MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
- 10-K Report Annual Report
- DEF 14A Proxy Proxy Statement
- 8-K/A Event Material agreement · Agreement ended
- 8-K Event Material agreement
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Other events
- 8-K Event Material agreement · Agreement ended
- 8-K Event Executive or director change
- 8-K Event Other events
- 8-K Event Regulation FD disclosure · Other events
- 8-K/A Event Acquisition or sale completed
- 8-K Event Material agreement · Unregistered share sale · Other events
- 10-K Report Annual Report
- 8-K Event Executive or director change
- 8-K Event Material agreement · Acquisition or sale completed · Executive or director change · Other events
- 8-K Event Material agreement · Unregistered share sale · Other events
- 8-K Event Unregistered share sale · Other events
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- 10-K Report Annual Report
Page 12 of 16 · 309 filings